New Hampshire HB648 mandates insurance coverage for diabetes services and supplies, including glucose monitoring devices and insulin.
New Hampshire HB648 requires insurers to cover medically appropriate and necessary equipment used to treat diabetes, including continuous glucose monitoring systems and traditional blood glucose monitors. It mandates that preferred providers or formularies include at least two of each kind of device, without requiring an endocrinology referral or prior authorization. The bill also caps the copayment for each 30-day supply of insulin at $30 and eliminates deductibles for insulin and glucose monitoring supplies.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.